These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 26067436)
41. Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease. Aziz NA; Anguelova GV; Marinus J; Lammers GJ; Roos RA Parkinsonism Relat Disord; 2010 Jun; 16(5):345-50. PubMed ID: 20236854 [TBL] [Abstract][Full Text] [Related]
42. Hypothalamic-pituitary-adrenal axis functioning in Huntington's disease and its association with depressive symptoms and suicidality. Hubers AA; van der Mast RC; Pereira AM; Roos RA; Veen LJ; Cobbaert CM; van Duijn E; Giltay EJ J Neuroendocrinol; 2015 Mar; 27(3):234-44. PubMed ID: 25565388 [TBL] [Abstract][Full Text] [Related]
43. Irritability and sociability in women with symptomatic premenstrual change. Marean M; Fox EE; Cumming CE; Cumming DC Women Health; 1998; 27(3):65-71. PubMed ID: 9698638 [TBL] [Abstract][Full Text] [Related]
44. Relationships Among Apathy, Health-Related Quality of Life, and Function in Huntington's Disease. Fritz NE; Boileau NR; Stout JC; Ready R; Perlmutter JS; Paulsen JS; Quaid K; Barton S; McCormack MK; Perlman SL; Carlozzi NE; J Neuropsychiatry Clin Neurosci; 2018; 30(3):194-201. PubMed ID: 29558861 [TBL] [Abstract][Full Text] [Related]
45. An Exploratory Study Investigating Autonomy in Huntington's Disease Gene Expansion Carriers. Hendel RK; Hellem MNN; Hjermind LE; Nielsen JE; Vogel A J Huntingtons Dis; 2022; 11(4):373-381. PubMed ID: 35964199 [TBL] [Abstract][Full Text] [Related]
46. A double blind evaluation of cognitive decline in a Norwegian cohort of asymptomatic carriers of Huntington's disease. van Walsem MR; Sundet K; Retterstøl L; Sundseth Ø J Clin Exp Neuropsychol; 2010 Jul; 32(6):590-8. PubMed ID: 19916101 [TBL] [Abstract][Full Text] [Related]
47. Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington's disease. Aziz NA; Anguelova GV; Marinus J; van Dijk JG; Roos RA Eur J Neurol; 2010 Aug; 17(8):1068-74. PubMed ID: 20192977 [TBL] [Abstract][Full Text] [Related]
48. Irritability and social isolation in dementia patients with and without depression. Shub D; Bass DM; Morgan RO; Judge KS; Snow AL; Wilson NL; Walder A; Murry B; Kunik ME J Geriatr Psychiatry Neurol; 2011 Dec; 24(4):229-34. PubMed ID: 22228830 [TBL] [Abstract][Full Text] [Related]
49. Prevalence of neuropsychiatric symptoms in young-onset compared to late-onset Alzheimer's disease - part 1: findings of the two-year longitudinal NeedYD-study. van Vliet D; de Vugt ME; Aalten P; Bakker C; Pijnenburg YA; Vernooij-Dassen MJ; Koopmans RT; Verhey FR Dement Geriatr Cogn Disord; 2012; 34(5-6):319-27. PubMed ID: 23208452 [TBL] [Abstract][Full Text] [Related]
50. Neuropsychiatry of Huntington's disease and other basal ganglia disorders. Rosenblatt A; Leroi I Psychosomatics; 2000; 41(1):24-30. PubMed ID: 10665265 [TBL] [Abstract][Full Text] [Related]
51. A Systematic Review of Neuropsychiatric Symptoms and Functional Capacity in Huntington's Disease. Sellers J; Ridner SH; Claassen DO J Neuropsychiatry Clin Neurosci; 2020; 32(2):109-124. PubMed ID: 31466515 [TBL] [Abstract][Full Text] [Related]
52. Assessment of involuntary choreatic movements in Huntington's disease--toward objective and quantitative measures. Reilmann R; Bohlen S; Kirsten F; Ringelstein EB; Lange HW Mov Disord; 2011 Oct; 26(12):2267-73. PubMed ID: 21661053 [TBL] [Abstract][Full Text] [Related]
53. Psychiatric disorders in Huntington's disease: a 2-year follow-up study. Reedeker W; van der Mast RC; Giltay EJ; Kooistra TA; Roos RA; van Duijn E Psychosomatics; 2012; 53(3):220-9. PubMed ID: 22458993 [TBL] [Abstract][Full Text] [Related]
54. Acute psychosis in a verified Huntington disease gene carrier with subtle motor signs: psychiatric criteria should be considered for the diagnosis. Nagel M; Rumpf HJ; Kasten M Gen Hosp Psychiatry; 2014; 36(3):361.e3-4. PubMed ID: 24576988 [TBL] [Abstract][Full Text] [Related]
55. Exploring the Structural Relationship Between Interviewer and Self-Rated Affective Symptoms in Huntington's Disease. Maltby J; Dale M; Underwood M; Rickards H; Callaghan J; J Neuropsychiatry Clin Neurosci; 2016; 28(3):236-8. PubMed ID: 26900736 [TBL] [Abstract][Full Text] [Related]
56. Treatment of the psychiatric manifestations of Huntington's disease: a review of the literature. Leroi I; Michalon M Can J Psychiatry; 1998 Nov; 43(9):933-40. PubMed ID: 9825166 [TBL] [Abstract][Full Text] [Related]
57. Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral blood. Mastrokolias A; Ariyurek Y; Goeman JJ; van Duijn E; Roos RA; van der Mast RC; van Ommen GB; den Dunnen JT; 't Hoen PA; van Roon-Mom WM Eur J Hum Genet; 2015 Oct; 23(10):1349-56. PubMed ID: 25626709 [TBL] [Abstract][Full Text] [Related]